Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media
NCT ID: NCT02527642
Last Updated: 2017-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
13 participants
INTERVENTIONAL
2015-07-31
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Global, G-TL, & Cornell Media
NCT03687697
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
NCT03522350
Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse Imaging
NCT01939626
Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation
NCT02802176
Immune Modulators and IVF
NCT02626702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mature oocytes will be randomized via a non-bias computer program into two to four of the study groups: G-TL commercial single step (Vitrolife), Vitrolife's sequential media, Cornell's single step , and Cornell's sequential media. Oocytes will be divided randomly among the various media dependent upon the number of mature oocytes. I.e.: 10 oocytes injected = 2 media groups; 15 oocytes injected = up to 3 media groups; 20 oocytes injected = up to 4 media groups.
"Best grade" embryos will be transferred regardless of media source. If embryos are transferred from multi-source media and if researchers are unable to determine the media source after transfer, the subject will not be included in the outcome data portion of the study- e.g pregnancy outcome.
The Time-Lapse monitoring system will be used as standard clinical practice to observe development and document timing of embryo cleavages and morphology dynamics.
Endpoints will be Day 3 and Day 5/6 embryo development, implantation and pregnancy rate. The study is approximately 2 months, the estimated time it takes a physician to perform one IVF-ART IVF- Assisted Reproductive Technology) treatment cycle. If embryos are frozen, the patient may be in the study until the time they choose to thaw the embryos or up to 1 year if they become pregnant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRM sequential media (C1/C2)
CRM sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.
embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
CRM single step media (C3)
CRM single step media is used to culture the embryos from oocyte fertilization to blastocyst stage.
embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Vitrolife media G1/2 Sequential
Vitrolife sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.
embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Vitrolife G-TL Time Lapse media Single Step
G-TL Time Lapse Single step (time lapse) media is formulated for continuous culture from oocyte fertilization to blastocyst stage.
embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must have 10 or greater than 10 mature oocytes, ICSI only
* Fresh or frozen (including donor) sperm can be used. Fresh oocytes only (including donor)
* Frozen embryos from this study can be included in the outcome portion of this study.
* Single or double Blastocyst transfer only
Exclusion Criteria
* 3 or more previous failed cycles
* Sperm obtained by testicular biopsy
* Previous enrollment in the study
* Non blastocyst transfer
* Co-culture patients
* Outcome data portion exclusion only:
Multi-source media transfers if researchers are unable to determine the media source after transfer.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vitrolife
INDUSTRY
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nikica Zaninovic, PhD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center fo Reproductive Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1411015635
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.